{"id":35703,"date":"2025-06-20T15:31:40","date_gmt":"2025-06-20T07:31:40","guid":{"rendered":"https:\/\/flcube.com\/?p=35703"},"modified":"2025-06-20T15:31:40","modified_gmt":"2025-06-20T07:31:40","slug":"cde-issues-new-requirements-for-ind-applications-of-innovative-drugs","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=35703","title":{"rendered":"CDE Issues New Requirements for IND Applications of Innovative Drugs"},"content":{"rendered":"\n<p>The Center for Drug Evaluation (CDE) of China&#8217;s National Medical Products Administration (NMPA) this week released three key documents: the \u201cRequirements for Investigational New Drug (IND) Application Dossiers of Innovative Drugs\u201d, \u201cEvaluation Report for IND Applications of Innovative Drugs\u201d, and \u201cKey Assessment Considerations for IND Applications of Innovative Drugs\u201d. The release marks the commencement of a one-month public consultation period.<\/p>\n\n\n\n<p><strong>Document Details<\/strong><br>The newly released documents outline specific submission requirements tailored for innovative chemical drugs, novel therapeutic biological products, and innovative vaccines. These guidelines cover a comprehensive range of technical requirements, including quality overviews, non-clinical and clinical summaries, pharmaceutical development data standards, and defined assessment parameters for non-clinical and clinical evaluations.<\/p>\n\n\n\n<p><strong>Significance<\/strong><br>These initiatives aim to streamline the review process for innovative drugs, ensuring that the quality, safety, and efficacy of new therapies are rigorously assessed while facilitating more efficient development and approval pathways for promising treatments.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/\u521b\u65b0\u836f\u4e34\u5e8a\u8bd5\u9a8c\u7533\u8bf7\u7533\u62a5\u8d44\u6599\u8981\u6c42\u6a21\u5757\u4e00.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of \u521b\u65b0\u836f\u4e34\u5e8a\u8bd5\u9a8c\u7533\u8bf7\u7533\u62a5\u8d44\u6599\u8981\u6c42\u6a21\u5757\u4e00.\"><\/object><a id=\"wp-block-file--media-5cb4abc7-2ea3-400f-a333-ace625657cb1\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/\u521b\u65b0\u836f\u4e34\u5e8a\u8bd5\u9a8c\u7533\u8bf7\u7533\u62a5\u8d44\u6599\u8981\u6c42\u6a21\u5757\u4e00.pdf\">\u521b\u65b0\u836f\u4e34\u5e8a\u8bd5\u9a8c\u7533\u8bf7\u7533\u62a5\u8d44\u6599\u8981\u6c42\u6a21\u5757\u4e00<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/\u521b\u65b0\u836f\u4e34\u5e8a\u8bd5\u9a8c\u7533\u8bf7\u7533\u62a5\u8d44\u6599\u8981\u6c42\u6a21\u5757\u4e00.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-5cb4abc7-2ea3-400f-a333-ace625657cb1\">Download<\/a><\/div>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/\u5316\u5b66\u836f\u54c1\u521b\u65b0\u836f\u4e34\u5e8a\u8bd5\u9a8c\u7533\u8bf7\u7533\u62a5\u8d44\u6599\u8981\u6c42\u6a21\u57572-5.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of \u5316\u5b66\u836f\u54c1\u521b\u65b0\u836f\u4e34\u5e8a\u8bd5\u9a8c\u7533\u8bf7\u7533\u62a5\u8d44\u6599\u8981\u6c42(\u6a21\u57572-5).\"><\/object><a id=\"wp-block-file--media-cdd6e2bd-2937-4fd1-b7cd-bb30e9d91dbc\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/\u5316\u5b66\u836f\u54c1\u521b\u65b0\u836f\u4e34\u5e8a\u8bd5\u9a8c\u7533\u8bf7\u7533\u62a5\u8d44\u6599\u8981\u6c42\u6a21\u57572-5.pdf\">\u5316\u5b66\u836f\u54c1\u521b\u65b0\u836f\u4e34\u5e8a\u8bd5\u9a8c\u7533\u8bf7\u7533\u62a5\u8d44\u6599\u8981\u6c42(\u6a21\u57572-5)<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/\u5316\u5b66\u836f\u54c1\u521b\u65b0\u836f\u4e34\u5e8a\u8bd5\u9a8c\u7533\u8bf7\u7533\u62a5\u8d44\u6599\u8981\u6c42\u6a21\u57572-5.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-cdd6e2bd-2937-4fd1-b7cd-bb30e9d91dbc\">Download<\/a><\/div>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/\u521b\u65b0\u578b\u6cbb\u7597\u7528\u751f\u7269\u5236\u54c1\u4e34\u5e8a\u8bd5\u9a8c\u7533\u8bf7\u7533\u62a5\u8d44\u6599\u8981\u6c42\uff08\u6a21\u57572-5\uff09.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of \u521b\u65b0\u578b\u6cbb\u7597\u7528\u751f\u7269\u5236\u54c1\u4e34\u5e8a\u8bd5\u9a8c\u7533\u8bf7\u7533\u62a5\u8d44\u6599\u8981\u6c42\uff08\u6a21\u57572-5\uff09.\"><\/object><a id=\"wp-block-file--media-26f0f7d3-e8b4-44a0-b67f-04c1b7ca1fe1\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/\u521b\u65b0\u578b\u6cbb\u7597\u7528\u751f\u7269\u5236\u54c1\u4e34\u5e8a\u8bd5\u9a8c\u7533\u8bf7\u7533\u62a5\u8d44\u6599\u8981\u6c42\uff08\u6a21\u57572-5\uff09.pdf\">\u521b\u65b0\u578b\u6cbb\u7597\u7528\u751f\u7269\u5236\u54c1\u4e34\u5e8a\u8bd5\u9a8c\u7533\u8bf7\u7533\u62a5\u8d44\u6599\u8981\u6c42\uff08\u6a21\u57572-5\uff09<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/\u521b\u65b0\u578b\u6cbb\u7597\u7528\u751f\u7269\u5236\u54c1\u4e34\u5e8a\u8bd5\u9a8c\u7533\u8bf7\u7533\u62a5\u8d44\u6599\u8981\u6c42\uff08\u6a21\u57572-5\uff09.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-26f0f7d3-e8b4-44a0-b67f-04c1b7ca1fe1\">Download<\/a><\/div>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/\u521b\u65b0\u578b\u75ab\u82d7\u4e34\u5e8a\u8bd5\u9a8c\u7533\u8bf7\u7533\u62a5\u8d44\u6599\u8981\u6c42\uff08\u6a21\u57572-5\uff09.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of \u521b\u65b0\u578b\u75ab\u82d7\u4e34\u5e8a\u8bd5\u9a8c\u7533\u8bf7\u7533\u62a5\u8d44\u6599\u8981\u6c42\uff08\u6a21\u57572-5\uff09.\"><\/object><a id=\"wp-block-file--media-0a4c5011-606e-45a3-8bc8-619564198bbf\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/\u521b\u65b0\u578b\u75ab\u82d7\u4e34\u5e8a\u8bd5\u9a8c\u7533\u8bf7\u7533\u62a5\u8d44\u6599\u8981\u6c42\uff08\u6a21\u57572-5\uff09.pdf\">\u521b\u65b0\u578b\u75ab\u82d7\u4e34\u5e8a\u8bd5\u9a8c\u7533\u8bf7\u7533\u62a5\u8d44\u6599\u8981\u6c42\uff08\u6a21\u57572-5\uff09<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/\u521b\u65b0\u578b\u75ab\u82d7\u4e34\u5e8a\u8bd5\u9a8c\u7533\u8bf7\u7533\u62a5\u8d44\u6599\u8981\u6c42\uff08\u6a21\u57572-5\uff09.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-0a4c5011-606e-45a3-8bc8-619564198bbf\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>The Center for Drug Evaluation (CDE) of China&#8217;s National Medical Products Administration (NMPA) this week&#8230;<\/p>\n","protected":false},"author":1,"featured_media":35704,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,11,4],"tags":[102,14],"class_list":["post-35703","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-drug","category-policy-regulatory","tag-cde","tag-nmpa"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>CDE Issues New Requirements for IND Applications of Innovative Drugs - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"The Center for Drug Evaluation (CDE) of China&#039;s National Medical Products Administration (NMPA) this week released three key documents: the \u201cRequirements for Investigational New Drug (IND) Application Dossiers of Innovative Drugs\u201d, \u201cEvaluation Report for IND Applications of Innovative Drugs\u201d, and \u201cKey Assessment Considerations for IND Applications of Innovative Drugs\u201d. The release marks the commencement of a one-month public consultation period.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=35703\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CDE Issues New Requirements for IND Applications of Innovative Drugs\" \/>\n<meta property=\"og:description\" content=\"The Center for Drug Evaluation (CDE) of China&#039;s National Medical Products Administration (NMPA) this week released three key documents: the \u201cRequirements for Investigational New Drug (IND) Application Dossiers of Innovative Drugs\u201d, \u201cEvaluation Report for IND Applications of Innovative Drugs\u201d, and \u201cKey Assessment Considerations for IND Applications of Innovative Drugs\u201d. The release marks the commencement of a one-month public consultation period.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=35703\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-20T07:31:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/2011.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=35703#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=35703\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"CDE Issues New Requirements for IND Applications of Innovative Drugs\",\"datePublished\":\"2025-06-20T07:31:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=35703\"},\"wordCount\":169,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=35703#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/2011.webp\",\"keywords\":[\"CDE\",\"NMPA\"],\"articleSection\":[\"Company\",\"Drug\",\"Policy \\\/ Regulatory\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=35703#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=35703\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=35703\",\"name\":\"CDE Issues New Requirements for IND Applications of Innovative Drugs - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=35703#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=35703#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/2011.webp\",\"datePublished\":\"2025-06-20T07:31:40+00:00\",\"description\":\"The Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) this week released three key documents: the \u201cRequirements for Investigational New Drug (IND) Application Dossiers of Innovative Drugs\u201d, \u201cEvaluation Report for IND Applications of Innovative Drugs\u201d, and \u201cKey Assessment Considerations for IND Applications of Innovative Drugs\u201d. The release marks the commencement of a one-month public consultation period.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=35703#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=35703\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=35703#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/2011.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/2011.webp\",\"width\":1080,\"height\":608,\"caption\":\"CDE Issues New Requirements for IND Applications of Innovative Drugs\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=35703#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CDE Issues New Requirements for IND Applications of Innovative Drugs\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"CDE Issues New Requirements for IND Applications of Innovative Drugs - Insight, China&#039;s Pharmaceutical Industry","description":"The Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) this week released three key documents: the \u201cRequirements for Investigational New Drug (IND) Application Dossiers of Innovative Drugs\u201d, \u201cEvaluation Report for IND Applications of Innovative Drugs\u201d, and \u201cKey Assessment Considerations for IND Applications of Innovative Drugs\u201d. The release marks the commencement of a one-month public consultation period.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=35703","og_locale":"en_US","og_type":"article","og_title":"CDE Issues New Requirements for IND Applications of Innovative Drugs","og_description":"The Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) this week released three key documents: the \u201cRequirements for Investigational New Drug (IND) Application Dossiers of Innovative Drugs\u201d, \u201cEvaluation Report for IND Applications of Innovative Drugs\u201d, and \u201cKey Assessment Considerations for IND Applications of Innovative Drugs\u201d. The release marks the commencement of a one-month public consultation period.","og_url":"https:\/\/flcube.com\/?p=35703","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-06-20T07:31:40+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/2011.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=35703#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=35703"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"CDE Issues New Requirements for IND Applications of Innovative Drugs","datePublished":"2025-06-20T07:31:40+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=35703"},"wordCount":169,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=35703#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/2011.webp","keywords":["CDE","NMPA"],"articleSection":["Company","Drug","Policy \/ Regulatory"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=35703#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=35703","url":"https:\/\/flcube.com\/?p=35703","name":"CDE Issues New Requirements for IND Applications of Innovative Drugs - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=35703#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=35703#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/2011.webp","datePublished":"2025-06-20T07:31:40+00:00","description":"The Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) this week released three key documents: the \u201cRequirements for Investigational New Drug (IND) Application Dossiers of Innovative Drugs\u201d, \u201cEvaluation Report for IND Applications of Innovative Drugs\u201d, and \u201cKey Assessment Considerations for IND Applications of Innovative Drugs\u201d. The release marks the commencement of a one-month public consultation period.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=35703#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=35703"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=35703#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/2011.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/2011.webp","width":1080,"height":608,"caption":"CDE Issues New Requirements for IND Applications of Innovative Drugs"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=35703#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"CDE Issues New Requirements for IND Applications of Innovative Drugs"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/2011.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/35703","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=35703"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/35703\/revisions"}],"predecessor-version":[{"id":35709,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/35703\/revisions\/35709"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/35704"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=35703"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=35703"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=35703"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}